Antonio Latella Selected Research

Cladribine

1/2016

Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Latella Research Topics

Disease

3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2016 - 03/2002
1	Bone Diseases (Bone Disease) 07/2014
1	Pain (Aches) 07/2014
1	Hypoalbuminemia 05/2010
1	Pneumothorax 02/2007
1	Fever (Fevers) 04/2003
1	Neutropenia 04/2003
1	Febrile Neutropenia 04/2003
1	Hepatomegaly 03/2002
1	Cholestasis 03/2002
1	Sclerosing Cholangitis 03/2002

Drug/Important Bio-Agent (IBA)

1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Cladribine FDA LinkGeneric 01/2016
1	Pharmaceutical PreparationsIBA 07/2014
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2014
1	NAD (NADH)IBA 07/2014
1	SteroidsIBA 07/2014
1	AlbuminsIBA 05/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2003
1	BilirubinIBA 03/2002
1	Alkaline PhosphataseIBA 03/2002
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2002
1	Transaminases (Aminotransferases)IBA 03/2002

Therapy/Procedure

2	Therapeutics 07/2014 - 04/2003
1	Aftercare (After-Treatment) 07/2014
1	Drug Therapy (Chemotherapy) 07/2014
1	Chest Tubes (Chest Tube) 02/2007
1	Liver Transplantation 03/2002